-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Mental and behavioural disorders
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
- Page 1 of 5
- next
41 results found filtered by Musculoskeletal system Remove Musculoskeletal system Filter Clear Search
-
Carpal tunnel syndrome: Technologies scoping report 15
- Published
- 29 May 2013
- Cycle of Improvement
- Evidence
-
Carpal tunnel syndrome: Advice Statement 006-13
- Published
- 29 May 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance no 280 - Rheumatoid arthritis (2nd line) - abatacept (rapid review of TA 234)
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance no 281 - Canakinumab for gout – terminated appraisal
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE MTA Guidance no 279 - Percutaneous vertebroplasty and percutaneous balloon kyphoplasty
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance No 254 - Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis
- Published
- 25 April 2012
- Cycle of Improvement
- Improvement
-
NICE STA Guidance No 247 – Tocilizumab for the treatment of rheumatoid arthritis
- Published
- 22 February 2012
- Cycle of Improvement
- Improvement
-
STA Guidance No 238 – Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
- Published
- 14 December 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 234 – abatacept for the treatment of rheumatoid arthritis
- Published
- 24 August 2011
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 233 – golimumab for the treatment of ankylosing spondylitis
- Published
- 24 August 2011
- Cycle of Improvement
- Evidence